Lucinda Rand

1.0k citations
9 papers · 801 indexed · h-index 8
Topics
Tuberculosis Research and Epidemiology (7 papers)Mycobacterium research and diagnosis (5 papers)Peptidase Inhibition and Analysis (2 papers)

In The Last Decade

Lucinda Rand

9 papers receiving 778 citations

Peers

Lucinda Rand
Comparison fields: 5 of 88
  • Infectious Diseases 443
  • Molecular Biology 419
  • Epidemiology 320
  • Molecular Medicine 175
  • Genetics 148
Replace Agnese Serafini with:
Agnese Serafini Italy
Ashley M. Sherrid United States
Rick Lyons United States
K Minch United States
Alessandro Cascioferro Italy
Eileen Pagán-Ramos United States
Chiew Ko United States
Richa Misra India
Saleena Ghanny United States
Rachel L. Leistikow United States
Lucinda Rand relative to Agnese Serafini Italy Agnese Serafini's profile →
Citations per field
00.5×1.6×
Agnese Serafini · 1×
Citations per year

Countries citing papers authored by Lucinda Rand

Since Specialization
Citations

This map shows the geographic impact of Lucinda Rand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucinda Rand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucinda Rand more than expected).

Fields of papers citing papers by Lucinda Rand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucinda Rand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucinda Rand. The network helps show where Lucinda Rand may publish in the future.

Co-authorship network of co-authors of Lucinda Rand

This figure shows the co-authorship network connecting the top 25 collaborators of Lucinda Rand. A scholar is included among the top collaborators of Lucinda Rand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucinda Rand. Lucinda Rand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 40
2 7
3 26
4 43
5 401
6 18
7 125
8 79
9 62

About Lucinda Rand

Lucinda Rand is a scholar working on Molecular Medicine, Infectious Diseases and Epidemiology, having authored 9 papers that have together received 801 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (5 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Molecular Medicine (175 citations), Infectious Diseases (443 citations) and Epidemiology (320 citations). Lucinda Rand has collaborated with scholars based in United Kingdom, Switzerland and Tanzania. Frequent co-authors include Sylvie Alonso, Kévin Pethe, Srinivasa P. S. Rao, Thomas Dick, Elaine O. Davis, Burkhard Springer, Jason Hinds, Roger S. Buxton, Peter Sander and Jon S. Friedland. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026